Browse the corpus

The complement system is a crucial part of the innate humoral immune system. The purpose of the complement system is to orchestrate opsonization, facilitate cytotoxic destruction formulate membrane attack complexes (MAC), and liberation of peptides that promote the inflammatory response. Complement deficiencies are primary immunodeficiencies that cause various clinical scenarios depending on the specific deficient complement protein. This activity outlines the evaluation and management of complement deficiency and highlights the role of the interprofessional team in the care of patients with this condition. Objectives: Identify the etiology of complement deficiency. Determine the appropriate evaluation of complement deficiency. Differentiate the management options available for complement deficiency. Describe interprofessional team strategies for improving care coordination and communication to advance the management of complement deficiency and improve outcomes. Access free multiple choice questions on this topic.

The immune system is the body’s defense mechanism against infections and comprises 2 pathways - the innate and adaptive pathways.[1] The innate pathway is present from birth and is pre-programmed. The innate immune system consists of the cellular component, which includes monocytes, macrophages, and natural killer cells, and the humoral component, which includes the complement system. The adaptive pathway develops during life with exposure to infection and increases affinity with experience. It consists of the cellular component, T cells, and the humoral component, which consists of antibodies made by B cells. The adaptive pathway facilitates improved destruction of the organism and forms memory cells for future infections. Complement deficiencies are primary immunodeficiencies that cause various clinical scenarios depending on the specific deficient complement protein. This can include an increased risk of a wide range of infectious and local or systemic inflammatory and thrombotic conditions.[2] Additionally, the complement system does not only act as the defense mechanism against infections, but it also works as a mediator in both the prevention of immune complex-related diseases and pathogenesis, such as systemic lupus erythematosus (SLE).[3][4][5] See Figure. Complement Cascade Schematic Diagram.

Complement deficiencies are usually hereditary. The most common type is autosomal recessive form, including C1, C2, C3, C4, C5, C6, C7, C8, C9, and Mannan-binding lectin deficiencies.[2] The X-linked recessive pattern has been described for properdin deficiency.[6] Other complement deficiencies are acquired through complement overconsumption, protein synthesis dysfunction, protein loss disorders, autoimmunity, and high catabolic states. Deficiencies of early components of the classical complement pathway, including C1, C4, and C2, are associated with encapsulated bacterial infections like Streptococcus Pneumoniae and Haemophilus Influenza type b.[7] A deficiency of C3 is associated with severe recurrent pyogenic infections early in life.[8] Deficiencies of the late common pathway (C5, C6, C7, C8, and C9) are associated with increased Neisseria infections, including Neisseria meningitidis and Neisseria gonorrhoeae. A properdin deficiency in the early alternative pathway is also associated with recurrent Neisseria infection.[9] A mannan-binding lectin deficiency has been linked to an increased frequency of pyogenic infections and sepsis, particularly in children and neonates when the adaptive immune system has not matured. In addition to the increased incidence of infection, an individual with early classical complement deficiency (C1, C4, or C2) frequently has a higher incidence of autoimmune disorders, especially systemic lupus erythematosus.[10] Early classical complements like C1 bind to cells undergoing apoptosis and facilitate the elimination of such cells. The body produces autoantibodies against these uncleared cells that result in autoimmune disorders.

Complement deficiencies are rare worldwide; high-risk populations are screened to estimate prevalence. The mannan-binding lectin (MBL) of the lectin-based pathway is the most prevalent form of complement deficiency in 5% of the White population, and it may be clinically silent. Apart from the MBL pathway, complement deficiencies are prevalent in 0.03% of the population.[11] Deficiency of C2 protein is the second most common form after MBL deficiency and is also clinically silent. C3 is a crucial player in the complement system as this protein is the last step of the early pathway, a precursor to C3a, the anaphylatoxin, and a facilitator of chemotaxis for neutrophils and macrophages. Among all patients with primary immunodeficiency diseases, approximately 5% have complement deficiency. The most common type of primary immunodeficiency is antibody deficiency, which occurs in approximately 65% of cases. In the cases of meningococcal infection, the prevalence rate is nearly 30%. Patients with C1q deficiency are observed to have a 93% chance of having SLE in the future. Similarly, C1rs deficiency is found to have a 57% association with SLE, and C4 deficiency is associated with a 75% association with SLE. Properdin and C2 deficiencies have been more commonly observed in the White population, C6 deficiencies have been observed to have a predisposition in Africans, and deficiencies in C8 and C9 are more commonly seen in Asian populations. Specifically, 2 distinct C8 deficiency states have been studied: C8 alpha-gamma deficiency, seen mostly in Afro-Caribbeans, Hispanics, and Japanese, and C8beta, mainly in Whites.

The complement system is a crucial part of the innate humoral immune system. The purpose of the complement system is to orchestrate opsonization, facilitate cytotoxic destruction, formulate MACs, and the liberation of peptides that promote the inflammatory response.[12] The complement system consists of 3 pathways, the classical, alternative, and lectin, initiated by distinct mechanisms. C1, C2, C4, and antigen-antibody immune complexes initiate the classical pathway. The lectin pathway is initiated by lectins, mannose-binding protein, sugar residues on the microbial surface, C4, and C2. The alternative pathway is initiated by C3, factor B, factor D, and properdin. These 3 pathways all share a common terminal pathway of C5 to C9. The outcome of the late pathway is to form a MAC that penetrates the cell membrane and facilitates cell death by lysis. Opsonization is the process of utilizing cleaved components of complement, C3b, and C4b, whereas inflammation is the process of utilizing C3a and C5a as anaphylatoxins. An intricate system regulates complement activity. The important components of this system include: Complement receptor 1 (CR1) Complement receptor 2 (CR2) Decay accelerating factor (DAF) A North African study looking into the basis of complement factor I deficiency in atypical hemolytic and uremic syndrome cases observed that the Ile357Met mutation could be a founding effect.[13] Cell surface-associated proteins and plasma proteins regulate different steps of the complement pathways; for instance, factor H and factor I stop the formation of C3 convertase in the alternative pathway. The enzyme C1q esterase inhibits the classic pathway's serine proteases C1r and C1s. The deficiency of these regulatory proteins leads to the overactivation of the complement system and an abundance of damaging inflammatory effects.[14] Two clinical conditions due to these deficiencies are paroxysmal nocturnal hemoglobinuria (PNH) and hereditary angioedema. A sampling of thirteen patients of hereditary angioedema, mainly women younger than 50 years, with low or normal levels of C1 inhibitor who got COVID-19, had neither severe COVID-19 nor severe acute angioedema.[15]

The history is the most important initial diagnostic tool for ruling out complement immunodeficiency. Recurrent Neisseria infection indicates possible late complement deficiencies (C5-C9) and early alternative pathway (properdin) deficiency. Severe recurrent pyogenic infection early in life should be an indication to rule out C3 immunodeficiency.[16] Complement deficiency should also be suspected in patients with recurrent sinopulmonary infection with normal humoral (antibody) immunity and with/without autoimmunity. Pyogenic infections and sepsis in children and neonates may indicate mannan-binding lectin deficiency. Infants may develop Leiner disease, characterized by wasting, recurrent diarrhea, and generalized seborrheic dermatitis. It is attributed to a pathology of C5. However, reports suggest a role of diminished C3 and reduced neutrophil mobility.[17][18] Thus, the etiology of Leiner disease is multifactorial. There are 3 major pathophysiological sequelae of complement deficiencies: 1. Inadequate Opsonization Opsonization is the process of making a pathogenic organism easy to ingest by the macrophage system. Defects in C3b or its cleavage product C3bi can lead to inadequate opsonization. The following can be various presentations of inadequate opsonization: Frequent sinopulmonary infections with pathogens such as Streptococcus pneumonia Autoimmune syndromes Encapsulated bacterial infections such as Neisseria meningitides and S pneumoniae Saccharomyces cerevisiae  [19] Atypical hemolytic uremic syndrome Membranoproliferative glomerulonephritis Age-related macular degeneration 2. Defects in Cell Lysis The defect in terminal cascade proteins also predisposes individuals to infection; however, the clinical history in these cases is different. The following are some consequences of these defects: Infection at an older age as opposed to patients with other complement deficiencies Lack of protection against many other nonbacterial pathogens, such as viruses, fungi, and mycobacteria 3. Immune Complex Diseases Patients with the classic pathway complement deficiencies are more prone to develop immune complex diseases. The following are some sequelae of such defects: Seizures secondary to neuropsychiatric systemic lupus erythematosus [20] Antiphospholipid antibody syndrome Arterial thrombosis [21]

Lack of protection against many other nonbacterial pathogens, such as viruses, fungi, and mycobacteria 3. Immune Complex Diseases Patients with the classic pathway complement deficiencies are more prone to develop immune complex diseases. The following are some sequelae of such defects: Seizures secondary to neuropsychiatric systemic lupus erythematosus [20] Antiphospholipid antibody syndrome Arterial thrombosis [21] The examination may be normal if the patient is not actively infected or has autoimmunity. A physical exam demonstrates crackles or bronchial breath sounds on lung auscultation at peripheral lung fields in a patient with active pneumococcal pneumonia. Egophony can be noted when significant consolidation is present. Examination of patients with meningitis frequently reveals meningismus. Patients may have positive Kernig or Brudzinski signs that show meningeal irritation. Other signs of Neisseria meningitidis infection include petechial rash and, in severe cases, can present with septic shock or disseminated intravascular coagulation (DIC).[22] Patients with early classical complement deficiencies may present with swollen and/or inflamed joints, suggesting autoimmunity.

Patients with recurrent infections of the respiratory tract without risk factors (negative human immunodeficiency virus, no asplenia, no other immunodeficiencies), as well as recurrent infections of encapsulated organisms such as Streptococcus pneumoniae, Neisseria meningitidis, and Hemophilus influenzae, should be screened for complement deficiency.[23] Patients with family members who have recurrent pneumococcal and meningococcal disease should also be screened. Screening for the complement system includes tests for the classical complement pathway (CH50), the alternate pathway (AH50), and the MBL pathway (MBL by ELISA). Low CH50 and normal AH50 suggest early classical complement component (C1, C2, and C4) deficiency. Low AH50 with normal CH50 suggests a deficiency of early alternative complement pathway factors (factor B, factor D, and properdin). Low AH50 and low CH50 suggest common terminal complement (C3, C5, C6, C7, C8, or C9) deficiency. If CH50 and AH50 are normal and the clinician still suspects complement deficiency, an MBL functional assay is indicated to screen for MBL deficiency.[24] Consider performing a head CT scan before a lumbar puncture in a patient suspected to have meningitis. Individuals with classic complement pathway deficiencies must be screened for consequences of immune complex diseases with the help of urinalysis and a complete blood cell count. A lumbar puncture should be performed to diagnose bacterial meningitis in cases suspected of having possible meningitis.

Complement deficiency is not typically treated with complement protein supplementation due to the infeasibility of overly frequent infusions, the risk of bloodborne infections, and the risk of developing antibodies to exogenous complement proteins. This condition is managed on a case-by-case basis with antibiotics for each episode of infection as well as regular visits with their immunologist.[25] Due to this population’s vulnerability to encapsulated organisms, patients need to be aware of the symptoms of meningococcal infection and seek care immediately if they should develop. Patients with complement deficiency should undergo all routine bacterial and viral vaccinations, especially meningococcal and pneumococcal vaccinations, and do not have a contraindication to live vaccines.[26] Some patients may develop flare-ups of their autoimmune disease. These patients should be managed with immunosuppressive therapy.

The differential diagnosis for these recurrent infections broadly includes B cell immunodeficiency, combined immunodeficiency, acquired immunodeficiencies, and asplenia with a predisposition for encapsulated organisms. The list of differential diagnoses is: Asplenia Common variable deficiency Hypogammaglobulinemia Human immunodeficiency virus Chronic granulomatous disease Chediak-Higashi syndrome Leukocyte adhesion deficiency Cyclic neutropenia SLE [27] Immunoglobulin A deficiency Immunoglobulin G deficiency Immunoglobulin D deficiency Immunoglobulin M deficiency Meningococcemia

The prognosis of this condition depends on the recurrence of infections and the severity of the episode of infection at the time. Many of these patients are at high risk for meningitis, which can be life-threatening if untreated.[22]

Complications include severe pneumococcal and meningococcal infections that can be fatal if not evaluated and treated adequately. Patients may also develop autoimmune disorders, especially systemic lupus erythematosus.

Patients with recurrent pneumococcal and/or meningococcal infections without predisposing risk factors should be referred to the allergist/immunologist. Also, consulting an infectious disease specialist or a rheumatologist is recommended to treat acute complications of complement deficiencies.

Patients and parents should be educated on the symptoms of serious illness, including meningitis, pneumonia, and sepsis. They should be instructed to seek care immediately if these signs develop. They should also seek care early for milder infections so that appropriate antibiotics can be started, and patients may be given prophylactic antibiotics for sudden recurrences. Vaccination is an important preventive measure, especially to prevent meningococcal and pneumococcal infections. Relatives of patients with complement deficiency should undergo complement screening as a diagnosis may allow prophylaxis to prevent possible disabling or life-threatening infections.[28] Complement deficiency should be looked for in adults with N meningitidis infection.[23] Early diagnosis, antibiotic prophylaxis, and vaccinations may allow normal life in hereditary C2 deficiency.[29][7]

Complement deficiency can lead to life-threatening infections as well as long-term autoimmune conditions and organ injuries. The interprofessional team of the primary care clinician and emergency medicine clinician must be aware of the clinical features of patients with complement deficiency or immunodeficiency in general. Relying on acute treatment when the patient is acutely ill may not be adequate to improve the patient's quality of life and clinical outcome. A high index of suspicion is important, and early referral to an allergist/immunologist may be important when the diagnosis of immunodeficiency is unclear.